These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27624330)

  • 1. Long-term outcome in young women with breast cancer: a population-based study.
    Fredholm H; Magnusson K; Lindström LS; Garmo H; Fält SE; Lindman H; Bergh J; Holmberg L; Pontén F; Frisell J; Fredriksson I
    Breast Cancer Res Treat; 2016 Nov; 160(1):131-143. PubMed ID: 27624330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up.
    Ohnstad HO; Borgen E; Falk RS; Lien TG; Aaserud M; Sveli MAT; Kyte JA; Kristensen VN; Geitvik GA; Schlichting E; Wist EA; Sørlie T; Russnes HG; Naume B
    Breast Cancer Res; 2017 Nov; 19(1):120. PubMed ID: 29137653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer in young women and prognosis: How important are proliferation markers?
    Fredholm H; Magnusson K; Lindström LS; Tobin NP; Lindman H; Bergh J; Holmberg L; Pontén F; Frisell J; Fredriksson I
    Eur J Cancer; 2017 Oct; 84():278-289. PubMed ID: 28844016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials.
    Loibl S; Jackisch C; Lederer B; Untch M; Paepke S; Kümmel S; Schneeweiss A; Huober J; Hilfrich J; Hanusch C; Gerber B; Eidtmann H; Denkert C; Costa SD; Blohmer JU; Nekljudova V; Mehta K; von Minckwitz G
    Breast Cancer Res Treat; 2015 Jul; 152(2):377-87. PubMed ID: 26109347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database.
    Chen HL; Zhou MQ; Tian W; Meng KX; He HF
    PLoS One; 2016; 11(10):e0165409. PubMed ID: 27798652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Young Age for Prognosis by Subtype in Women with Early Breast Cancer.
    Lian W; Fu F; Lin Y; Lu M; Chen B; Yang P; Zeng B; Huang M; Wang C
    Sci Rep; 2017 Sep; 7(1):11625. PubMed ID: 28912475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013.
    Ehinger A; Malmström P; Bendahl PO; Elston CW; Falck AK; Forsare C; Grabau D; Rydén L; Stål O; Fernö M;
    Acta Oncol; 2017 Jan; 56(1):68-74. PubMed ID: 27762648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luminal B subtype: a key factor for the worse prognosis of young breast cancer patients in China.
    Tang LC; Jin X; Yang HY; He M; Chang H; Shao ZM; Di GH
    BMC Cancer; 2015 Mar; 15():201. PubMed ID: 25885213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Worse prognosis for young women with breast cancer].
    Fredriksson I; Fredholm H
    Lakartidningen; 2017 Feb; 114():. PubMed ID: 28221401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should women younger than 40 years of age with invasive breast cancer have a mastectomy? 15-year outcomes in a population-based cohort.
    Cao JQ; Truong PT; Olivotto IA; Olson R; Coulombe G; Keyes M; Weir L; Gelmon K; Bernstein V; Woods R; Speers C; Tyldesley S
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):509-17. PubMed ID: 25194665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast Cancer Subtypes in Patients Aged 70 Years and Older.
    Königsberg R; Pfeiler G; Hammerschmid N; Holub O; Glössmann K; Larcher-Senn J; Dittrich C
    Cancer Invest; 2016 May; 34(5):197-204. PubMed ID: 27215407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival.
    Partridge AH; Hughes ME; Warner ET; Ottesen RA; Wong YN; Edge SB; Theriault RL; Blayney DW; Niland JC; Winer EP; Weeks JC; Tamimi RM
    J Clin Oncol; 2016 Sep; 34(27):3308-14. PubMed ID: 27480155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes.
    He ZY; Wu SG; Zhou J; Li FY; Lin Q; Lin HX; Sun JY
    PLoS One; 2015; 10(3):e0119105. PubMed ID: 25781605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer subtype and survival by parity and time since last birth.
    De Mulder H; Laenen A; Wildiers H; Punie K; Poppe A; Remmerie C; Lefrère H; Nevelsteen I; Smeets A; Van Nieuwenhuysen E; Han S; Van Limbergen E; Floris G; Vergote I; Neven P
    Breast Cancer Res Treat; 2018 Jun; 169(3):481-487. PubMed ID: 29426984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of age, intrinsic subtype and local treatment on long-term local-regional recurrence and breast cancer mortality among low-risk breast cancer patients.
    Laurberg T; Alsner J; Tramm T; Jensen V; Lyngholm CD; Christiansen PM; Overgaard J
    Acta Oncol; 2017 Jan; 56(1):59-67. PubMed ID: 27846764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of breast cancer molecular subtypes in routine clinical care: A large prospective cohort study.
    Hennigs A; Riedel F; Gondos A; Sinn P; Schirmacher P; Marmé F; Jäger D; Kauczor HU; Stieber A; Lindel K; Debus J; Golatta M; Schütz F; Sohn C; Heil J; Schneeweiss A
    BMC Cancer; 2016 Sep; 16(1):734. PubMed ID: 27634735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local recurrence following breast-conserving treatment in women aged 40 years or younger: trends in risk and the impact on prognosis in a population-based cohort of 1143 patients.
    van Laar C; van der Sangen MJ; Poortmans PM; Nieuwenhuijzen GA; Roukema JA; Roumen RM; Tjan-Heijnen VC; Voogd AC
    Eur J Cancer; 2013 Oct; 49(15):3093-101. PubMed ID: 23800672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving treatment strategies for inflammatory breast cancer: a population-based survival analysis.
    Panades M; Olivotto IA; Speers CH; Shenkier T; Olivotto TA; Weir L; Allan SJ; Truong PT
    J Clin Oncol; 2005 Mar; 23(9):1941-50. PubMed ID: 15774787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locoregional recurrence after breast-conserving therapy remains an independent prognostic factor even after an event free interval of 10 years in early stage breast cancer.
    Tanis E; van de Velde CJ; Bartelink H; van de Vijver MJ; Putter H; van der Hage JA
    Eur J Cancer; 2012 Aug; 48(12):1751-6. PubMed ID: 22446021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between body mass index and the expression of hormone receptors or human epidermal growth factor receptor 2 with respect to breast cancer survival.
    Jeon YW; Kang SH; Park MH; Lim W; Cho SH; Suh YJ
    BMC Cancer; 2015 Nov; 15():865. PubMed ID: 26546331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.